Last 12 months
Inside the activity.
22 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 6 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 10 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 6 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2020 Filed Sep 16, 2020 22:01 UTC |
Holliday KeithChief Technology Officer
|
Exercise / conversionCommon Stock | 1,286 | $7.52 | $9,670.72 |
DisclosureSEC source: 0001209191-20-050755 · doc4.xml · nonDerivative · entry 1 Holliday Keith · CIK 0001678691 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,733 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2020 Filed Sep 11, 2020 20:07 UTC |
Moore John CDirector
|
SaleCommon Stock | 137,331 | $52.04 | $7,146,705.24 |
DisclosureSEC source: 0001209191-20-050130 · doc4.xml · nonDerivative · entry 1 Moore John C · CIK 0001426569 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 21,387 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.34 to $52.67, inclusive. F2 · ownership.nature: Shares allocated to reporting person's family trust. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:30 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock Options · Derivative | 8,000 | $0.00 Strike: $16.15 | $0.00 |
DisclosureSEC source: 0001209191-20-046451 · doc4.xml · derivative · entry 9 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,476 Underlying: Common Stock · 8,000 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:30 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock Options · Derivative | 11,574 | $0.00 Strike: $8.64 | $0.00 |
DisclosureSEC source: 0001209191-20-046451 · doc4.xml · derivative · entry 8 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,574 shares Expires 2025-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:30 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock Options · Derivative | 5,822 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001209191-20-046451 · doc4.xml · derivative · entry 7 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,822 shares Expires 2026-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:30 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock Options · Derivative | 16,206 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001209191-20-046451 · doc4.xml · derivative · entry 6 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,206 shares Expires 2027-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:30 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
SaleCommon Stock | 41,602 | $51.22 | $2,130,854.44 |
DisclosureSEC source: 0001209191-20-046451 · doc4.xml · nonDerivative · entry 5 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,794 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.20 to $53.10, inclusive. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:30 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock | 8,000 | $16.15 | $129,200.00 |
DisclosureSEC source: 0001209191-20-046451 · doc4.xml · nonDerivative · entry 4 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,396 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:30 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock | 11,574 | $8.64 | $99,999.36 |
DisclosureSEC source: 0001209191-20-046451 · doc4.xml · nonDerivative · entry 3 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,396 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:30 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock | 5,822 | $7.52 | $43,781.44 |
DisclosureSEC source: 0001209191-20-046451 · doc4.xml · nonDerivative · entry 2 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:30 UTC |
Hayashida Jon K.VP, Global Clinical, Medical
|
Exercise / conversionCommon Stock | 16,206 | $9.30 | $150,715.80 |
DisclosureSEC source: 0001209191-20-046451 · doc4.xml · nonDerivative · entry 1 Hayashida Jon K. · CIK 0001781825 · VP, Global Clinical, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 22:28 UTC |
Williams Patrick F.Chief Financial Officer
|
GrantCommon Stock | 30,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-046450 · doc4.xml · nonDerivative · entry 1 Williams Patrick F. · CIK 0001562229 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,727 F1 · balance_after: Award of 30,727 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights. Regarding half of the RSUs, 15,363, 1/3 of the shares (5121) will vest on 8/10/21, 1/3 of the shares (5121) will vest on 8/10/22, and 1/3 of the shares (5121) will vest on 8/10/23. Regarding the other half of the RSUs, 15,364, they may vest based on achievement of pre-established, quantitative corporate financial performance metrics. Read SEC document |
| July 30, 2020 Filed Aug 4, 2020 21:24 UTC |
SILVERMAN LOUDirector
|
GrantCommon Stock | 2,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-044768 · doc4.xml · nonDerivative · entry 1 SILVERMAN LOU · CIK 0001249935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,850 F1 · shares: The restrictions on the 2117 restricted shares of common stock awarded on his election to the Board of Directors lapse on the earlier of July 30, 2021 or the Corporation's 2021 Annual Meeting, subject to his continued service through that date. Read SEC document |
| July 30, 2020 Filed Aug 4, 2020 21:21 UTC |
FARRELL STEPHEN CDirector
|
GrantCommon Stock | 2,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-044762 · doc4.xml · nonDerivative · entry 1 FARRELL STEPHEN C · CIK 0001188757 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,808 F1 · shares: The restrictions on the 2117 restricted shares of common stock awarded on his election to the Board of Directors lapse on the earlier of July 30, 2021 or the Corporation's 2021 Annual Meeting, subject to his continued service through that date. Read SEC document |
| July 30, 2020 Filed Aug 4, 2020 20:27 UTC |
Kliman Gilbert HDirector
|
GrantCommon Stock | 2,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-044688 · doc4.xml · nonDerivative · entry 1 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,581 F1 · shares: The restrictions on the 2117 restricted shares of common stock awarded on his election to the Board of Directors lapse on the earlier of July 30, 2021 or the Corporation's 2021 Annual Meeting, subject to his continued service through that date. Read SEC document |
| July 30, 2020 Filed Aug 4, 2020 20:31 UTC |
Moore John CDirector
|
GrantCommon Stock | 2,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-044693 · doc4.xml · nonDerivative · entry 1 Moore John C · CIK 0001426569 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,117 F1 · shares: The restrictions on the 2117 restricted shares of common stock awarded on his election to the Board of Directors lapse on the earlier of July 30, 2021 or the Corporation's 2021 Annual Meeting, subject to his continued service through that date. Read SEC document |
| July 30, 2020 Filed Aug 4, 2020 20:24 UTC |
FRINZI THOMAS GDirector
|
GrantCommon Stock | 2,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-044682 · doc4.xml · nonDerivative · entry 1 FRINZI THOMAS G · CIK 0001663458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,117 F1 · shares: The restrictions on the 2117 restricted shares of common stock awarded on his election to the Board of Directors lapse on the earlier of July 30, 2021 or the Corporation's 2021 Annual Meeting, subject to his continued service through that date. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 21:28 UTC |
BROADWOOD PARTNERS, L.P.10% owner
Bradsher Neal C10% owner
BROADWOOD CAPITAL INC10% owner
|
OtherCommon Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0000919574-20-004440 · ownership.xml · nonDerivative · entry 2 BROADWOOD PARTNERS, L.P. · CIK 0001278386 · 10% owner BRADSHER NEAL C · CIK 0001278388 · 10% owner BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnote Disclosed balance after: 10,795,348 F1 · kind: The shares were transferred to a limited partner in Broadwood Partners, L.P. No shares were sold by Broadwood Partners, L.P. F1 · price: The shares were transferred to a limited partner in Broadwood Partners, L.P. No shares were sold by Broadwood Partners, L.P. F2 · ownership.nature: The reported securities are directly owned by Broadwood Partners, L.P. and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners, L.P. and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 21:28 UTC |
BROADWOOD PARTNERS, L.P.10% owner
Bradsher Neal C10% owner
BROADWOOD CAPITAL INC10% owner
|
OtherCommon Stock | 4,062 | $0.00 | $0.00 |
DisclosureSEC source: 0000919574-20-004440 · ownership.xml · nonDerivative · entry 1 BROADWOOD PARTNERS, L.P. · CIK 0001278386 · 10% owner BRADSHER NEAL C · CIK 0001278388 · 10% owner BROADWOOD CAPITAL INC · CIK 0001278387 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,795,348 F1 · kind: The shares were transferred to a limited partner in Broadwood Partners, L.P. No shares were sold by Broadwood Partners, L.P. F1 · price: The shares were transferred to a limited partner in Broadwood Partners, L.P. No shares were sold by Broadwood Partners, L.P. F2 · ownership.direct: The reported securities are directly owned by Broadwood Partners, L.P. and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners, L.P. and Neal C. Bradsher as President of Broadwood Capital, Inc. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:03 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
Exercise / conversionCommon Stock Options · Derivative | 20,000 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001209191-20-037311 · doc4.xml · derivative · entry 5 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2023-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested in three equal installments on March 4, 2014, March 4, 2015, and March 4, 2016. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:03 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
Exercise / conversionCommon Stock Options · Derivative | 19,215 | $0.00 Strike: $11.00 | $0.00 |
DisclosureSEC source: 0001209191-20-037311 · doc4.xml · derivative · entry 4 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,215 shares Expires 2022-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vested in three equal installments on March 2, 2013, March 2, 2014, and March 2, 2015. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:03 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
SaleCommon Stock | 39,215 | $44.07 | $1,728,205.05 |
DisclosureSEC source: 0001209191-20-037311 · doc4.xml · nonDerivative · entry 3 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,950 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.00 to $44.38, inclusive. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:03 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
Exercise / conversionCommon Stock | 20,000 | $5.34 | $106,800.00 |
DisclosureSEC source: 0001209191-20-037311 · doc4.xml · nonDerivative · entry 2 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,165 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:03 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
Exercise / conversionCommon Stock | 19,215 | $11.00 | $211,365.00 |
DisclosureSEC source: 0001209191-20-037311 · doc4.xml · nonDerivative · entry 1 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,165 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 20:01 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
Exercise / conversionCommon Stock Options · Derivative | 785 | $0.00 Strike: $11.00 | $0.00 |
DisclosureSEC source: 0001209191-20-036240 · doc4.xml · derivative · entry 3 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,215 Underlying: Common Stock · 785 shares Expires 2022-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested in three equal installments on March 2, 2013, March 2, 2014, and March 2, 2015. Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 20:01 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
SaleCommon Stock | 785 | $44.00 | $34,540.00 |
DisclosureSEC source: 0001209191-20-036240 · doc4.xml · nonDerivative · entry 2 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,950 Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 20:01 UTC |
Blickensdoerfer Hans-MartinSr. VP, Comm. Ops, China
|
Exercise / conversionCommon Stock | 785 | $11.00 | $8,635.00 |
DisclosureSEC source: 0001209191-20-036240 · doc4.xml · nonDerivative · entry 1 Blickensdoerfer Hans-Martin · CIK 0001488891 · Sr. VP, Comm. Ops, China 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:18 UTC |
Kliman Gilbert HDirector
|
GrantCommon Stock | 464 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-033978 · doc4.xml · nonDerivative · entry 1 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464 F1 · balance_after: The restrictions on the 464 restricted shares of common stock lapse on July 30, 2020, the expected date of the Corporation's 2020 Annual Meeting, subject to Dr. Kliman's continued service through that date. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:16 UTC |
FRINZI THOMAS GDirector
|
GrantCommon Stock Options · Derivative | 971 | $0.00 Strike: $39.73 | $0.00 |
DisclosureSEC source: 0001209191-20-033973 · doc4.xml · derivative · entry 1 FRINZI THOMAS G · CIK 0001663458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 971 Underlying: Common Stock · 971 shares Expires 2030-07-29 F1 · derivative.exercise_date: These 971 stock options vest in full on July 30, 2020, subject to Mr. Frinzi's continued service through the vesting date. Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
Exercise / conversionCommon Stock Options · Derivative | 8,522 | $0.00 Strike: $35.98 | $0.00 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · derivative · entry 21 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,374 Underlying: Common Stock · 8,522 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
Exercise / conversionCommon Stock Options · Derivative | 6,292 | $0.00 Strike: $29.80 | $0.00 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · derivative · entry 20 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,495 Underlying: Common Stock · 6,292 shares Expires 2028-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
Exercise / conversionCommon Stock Options · Derivative | 13,333 | $0.00 Strike: $16.50 | $0.00 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · derivative · entry 19 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 Underlying: Common Stock · 13,333 shares Expires 2028-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
Exercise / conversionCommon Stock Options · Derivative | 12,500 | $0.00 Strike: $15.54 | $0.00 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · derivative · entry 18 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2024-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
Exercise / conversionCommon Stock Options · Derivative | 20,000 | $0.00 Strike: $11.02 | $0.00 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · derivative · entry 17 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2022-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
Exercise / conversionCommon Stock Options · Derivative | 50,000 | $0.00 Strike: $11.02 | $0.00 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · derivative · entry 16 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2022-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
Exercise / conversionCommon Stock Options · Derivative | 21,875 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · derivative · entry 15 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625 Underlying: Common Stock · 21,875 shares Expires 2027-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
Exercise / conversionCommon Stock Options · Derivative | 20,000 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · derivative · entry 14 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2026-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
Exercise / conversionCommon Stock Options · Derivative | 20,000 | $0.00 Strike: $7.35 | $0.00 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · derivative · entry 13 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2025-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
Exercise / conversionCommon Stock Options · Derivative | 20,000 | $0.00 Strike: $5.34 | $0.00 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · derivative · entry 12 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2023-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
SaleCommon Stock | 192,522 | $40.00 | $7,700,880.00 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · nonDerivative · entry 11 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,185 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.09 inclusive. Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
GrantCommon Stock | 8,522 | $35.98 | $306,621.56 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · nonDerivative · entry 10 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,707 Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
GrantCommon Stock | 6,292 | $29.80 | $187,501.60 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · nonDerivative · entry 9 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,185 Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
GrantCommon Stock | 13,333 | $16.50 | $219,994.50 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · nonDerivative · entry 8 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,893 Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
GrantCommon Stock | 12,500 | $15.54 | $194,250.00 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · nonDerivative · entry 7 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,560 Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
GrantCommon Stock | 20,000 | $11.02 | $220,400.00 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · nonDerivative · entry 6 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,060 Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
GrantCommon Stock | 50,000 | $11.02 | $551,000.00 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · nonDerivative · entry 5 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,060 Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
GrantCommon Stock | 21,875 | $9.30 | $203,437.50 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · nonDerivative · entry 4 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,060 Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
GrantCommon Stock | 20,000 | $7.52 | $150,400.00 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · nonDerivative · entry 3 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,185 Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
GrantCommon Stock | 20,000 | $7.35 | $147,000.00 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · nonDerivative · entry 2 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,185 Read SEC document |
| May 21, 2020 Filed May 26, 2020 20:16 UTC |
Gesten Samuel JChief Legal Officer
|
GrantCommon Stock | 20,000 | $5.34 | $106,800.00 |
DisclosureSEC source: 0001209191-20-031993 · doc4.xml · nonDerivative · entry 1 Gesten Samuel J · CIK 0001496615 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,185 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.